Statistics from Altmetric.com
Colleagues, I am writing to give you a mid-year progress report for the Journal of Investigative Medicine (JIM).
In the environment of ongoing COVID-19 challenges, with increasing clinical and/or administrative responsibilities for all researchers, JIM has continued to sustain the growth we witnessed in 2020. Here are some highlights for 2021 when compared with the data from June 2020.
There has been a steady increase in submissions over the past 2 years. Through June 2021, submissions have grown 50% versus the same time period in 2020 (figure 1).
The editorial team continues to work to improve the quality of JIM submissions, as evidenced by a decreased acceptance rate for all papers of 25% (figure 2).
Web traffic has been …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.